HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Superselective embolisation for intractable idiopathic epistaxis.

Abstract
37 patients with intractable idiopathic epistaxis were treated with superselective embolisation between 1995 and 1999. A total of 40 embolisations was performed, including three procedures for recurrence. The embolic material was gelatin sponge in 27 procedures, microcoils in 9 and both gelatin sponge and microcoils in 4. Immediate cessation of nasal bleeding was obtained in all patients after embolisation. Recurrent epistaxis occurred in 2 (5.4%) of the 37 patients within 7 days after initial embolisation, giving a short-term success rate of 94.6%. The long-term follow-up ranged from 1-51 months (mean 21.6 months). Late re-bleeding occurred in two patients, giving a long-term success rate of 94.6%. Two patients underwent re-embolisation; it was necessary to embolise the ipsilateral facial artery and/or the contralateral internal maxillary as well as the ipsilateral maxillary artery. Although the overall complication rate was 45.0%, no major complications occurred. Superselective embolisation with gelatin sponge is an effective and safe treatment technique for intractable idiopathic epistaxis.
AuthorsT Oguni, Y Korogi, T Yasunaga, T Sadanaga, H Uozumi, K Kawanaka, S Sumi, M Takahashi
JournalThe British journal of radiology (Br J Radiol) Vol. 73 Issue 875 Pg. 1148-53 (Nov 2000) ISSN: 0007-1285 [Print] England
PMID11144790 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Embolization, Therapeutic (methods)
  • Epistaxis (diagnostic imaging, etiology, therapy)
  • Female
  • Gelatin Sponge, Absorbable (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Radiography
  • Recurrence
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: